MHRA updates Guidance on Sourcing Medicines for the UK Market
The UK Medicines & Healthcare Products Regulatory Agency (MHRA) has updated its guidance on sourcing medicines for the UK market.
The document, which was first published on 31 December 2020, provides information on sourcing medicines that can be supplied by holders of wholesale distributor authorisations (WDAs) based in the UK.
The guidance covers the following aspects:
- Importing authorised medicines into the UK from a source which is on the approved country for import list
- Importing human medicines from a country on the list – for use as a special medicinal product
- Procuring human medicines from a country on the list for export purposes
- Importing medicines from a country on the list for supply to the United Kingdom parallel import market
The latest updates, published on 30 December 2024, reflect the new UK-wide licensing arrangements for human medicines that came into effect from 01 January 2025 as part of the Windsor Framework.
The complete guidance is available on the MHRA website.
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates